Central serous chorioretinopathy associated with testosterone therapy [6]

Eye

Volumn 20, Issue 4, 2006, Pages 503-505

  Ahad, M Ali ^a,c   Chua, C N ^b   Evans, N M ^a  

^a Royal Eye Infirmary   (United Kingdom)

^b OXFORD EYE HOSPITAL   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; TESTOSTERONE;

ADULT; ANAMNESIS; ANTERIOR EYE SEGMENT; CASE REPORT; CENTRAL SEROUS RETINOPATHY; DISEASE DURATION; EYE DISEASE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LETTER; MALE; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; SLIT LAMP; TESTOSTERONE BLOOD LEVEL; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 33645770234     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701905     Document Type: Letter

References (10)

1. Bouzas EA, Scott MH, Mastorakos S, Chrousos GP, Kaiser-Kupfer MI. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993; 111(9): 1229-1233.
2. Spraul CW, Lang GE, Lang GK. Retinal pigment epithelial changes associated with systemic corticosteroid treatment. Report of cases and review of literature. Ophthalmologica 1998; 212(2): 142-148.
3. Schatz H, Madeira D, Johnson RN, McDonald HR. Central serous chorioretinopathy occurring in patients 60 years of age or older. Ophthalmology 1992; 99(1): 63-67.
4. Gass JDM, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995; 102(5): 737-747.
5. Nolten WE, Rueckert PA. Elevated free cortisol index in pregnancy: possible regulatory mechanism. Am J Obstet Gynecol 1981; 139(4): 492-498.
6. Williams Jr RB, Lane JD, Kuhn CM, Melosh W, White AD, Schanberg SM. Type A behaviour and elevated physiological and neuroendocrine responses to cognitive tasks. Science 1982; 218(4571): 483-485.
7. Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997; 146(8): 609-617.
8. Zumoff B, Rosenfeld RS, Friedman M, Byers SO, Rosenman RH, Hellman L. Elevated daytime urinary excretion of testosterone glucuronide in men with the type A behavior pattern. Psychosom Med 1984; 46(3): 223-225.
9. Laudat MH, Guilhaume B, Blot P, Fournier C, Giauque JP, Luton JP. The hormonal state of pregnancy: Modification of cortisol and testosterone. Ann Endocrinol (Paris) 1987; 48(4): 334-338.
10. Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I et al. Identification of androgen receptor protein and 5 alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000; 84(1): 76-84.